Skip navigation

British Medical Journal Asks Whether Pharma Companies Are Inventing Diseases

Are CME providers being used by the pharmaceutical industry to legitimize a treatment for a condition that isn’t really a disease? Did GlaxoSmithKline “invent” irritable bowel syndrome in part by underwriting CME on the subject? These uncomfortable questions have been raised in a new article appearing in the April 13 issue of the British Medical Journal.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.